1 – 10 of 16
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Next-Generation Gene Therapy for Parkinson's Disease Using Engineered Viral Vectors
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Repairing the brain : Gene therapy
(
- Contribution to journal › Scientific review
- 2015
-
Mark
A doctor's dilemma
(
- Contribution to journal › Article
- 2014
-
Mark
Heat Shock Protein 70 Reduces alpha-Synuclein-Induced Predegenerative Neuronal Dystrophy in the alpha-Synuclein Viral Gene Transfer Rat Model of Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease : a dose escalation, open-label, phase 1/2 trial
(
- Contribution to journal › Article
-
Mark
Hybrid biosynthetic gene therapy vector development and dual engineering capacity
(
- Contribution to journal › Article
- 2010
-
Mark
In vitro and in vivo effects of polyethylene glycol (PEG)-modified lipid in DOTAP/cholesterol-mediated gene transfection
(
- Contribution to journal › Article
- 2009
-
Mark
Intravitreal delivery of AAV8 retinoschisin results in cell type-specific gene expression and retinal rescue in the Rs1-KO mouse
(
- Contribution to journal › Article
- 2007
-
Mark
Proteomic investigation of glioblastoma cell lines treated with wild-type p53 and cytotoxic chemotherapy demonstrates an association between galectin-1 and p53 expression
(
- Contribution to journal › Article
-
Mark
Retinoschisin gene therapy and natural history in the Rs1h-KO mouse : Long-term rescue from retinal degeneration
(
- Contribution to journal › Article